Alteração de sede deferida
#25.7
02/10/2026
RPI 2875
Application data
Number
112023026160Type
Filing
Publication
PCT
US2022073214 The application was filed at the INPI on 06/28/2022. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 02/10/2026. We update with every new RPI gazette, published weekly.
Applicants
NEUROCRINE BIOSCIENCES INC.
US
Inventors
G. L. (pessoa física)
US
IPC Classification
Priority claims
US
63/216,877 · 06/30/2021
US
63/279,815 · 11/16/2021
US
63/298,291 · 01/11/2022
Abstract
VALBENAZINA PARA USO NO TRATAMENTO DE DISCINESIA DEVIDO À PARALISIA CEREBRAL. A presente invenção refere-se a um método para tratar a discinesia devido à paralisia cerebral em um paciente com necessidade do mesmo, compreendendo: administrar um inibidor do transportador vesicular de monoamina 2 (VMAT2) ao paciente com necessidade do mesmo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#25.7
02/10/2026
RPI 2875
#1.3
03/05/2024
RPI 2774
#1.1
12/19/2023
RPI 2763
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.